CpG methylation in the promoter region has been shown to be important in the regulation of genes implicated in malignant transformation. The present study was designed to test the hypothesis that CpG methylation of the promoter region of the E-cadherin gene may inactivate its expression in renal cel
Methylation of promoter region ofRAR-β2 gene in renal cell, breast, and ovarian carcinomas
✍ Scribed by D. S. Khodyrev; V. I. Loginov; I. V. Pronina; T. P. Kazubskaya; R. F. Garkavtseva; E. A. Braga
- Book ID
- 110199602
- Publisher
- SP MAIK Nauka/Interperiodica
- Year
- 2008
- Tongue
- English
- Weight
- 181 KB
- Volume
- 44
- Category
- Article
- ISSN
- 1022-7954
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Homozygous deletion and loss of heterozygosity (LOH) at chromosome 3p21 have been observed in several types of human cancer including lung cancer and breast cancer. In previous work, we cloned and identified the human RAS association domain family 1A gene (RASSF1A) from the lung tumor suppressor loc
The FHIT gene locus at 3p14.2 covers about 500 kb, including the fragile site FRA3B and the constitutional t(3;8) breakpoint associated with the development of multiple renal cell carcinomas (RCC). A terminal deletion of the short arm of chromosome 3 with the most distal breakpoint in the FRA3B regi